Lung cancer epidemiology and genetics

Journal of Thoracic Imaging

Volumn 14, Issue 4, 1999, Pages 228-234

  Bepler, Gerold ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Diet; Family history; Gender; Lung cancer; Race; Risk assessment; Susceptibility genes

Indexed keywords

ACETYLTRANSFERASE 2; CYTOCHROME P450; GLUTATHIONE TRANSFERASE; MYELOPEROXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE FERRIHEMOPROTEIN REDUCTASE; UNCLASSIFIED DRUG;

ALLELISM; CANCER GENETICS; CANCER SUSCEPTIBILITY; CONFERENCE PAPER; HUMAN; HUMAN CELL; LUNG CANCER; POPULATION RISK; RECURRENT DISEASE; RISK FACTOR; SMOKING; SOCIOECONOMICS; UNITED STATES;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUNG NEOPLASMS; MALE; MUTATION; RISK FACTORS;

EID: 0032886554     PISSN: 08835993     EISSN: 15360237     Source Type: Journal    
DOI: 10.1097/00005382-199910000-00002     Document Type: Article

References (58)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998. Ca Cancer J Clin 1998;48:6-29.
2. Parker SL, Davis KJ, Wingo PA, Ries LA, Heath CW. Cancer statistics by race and ethnicity. Calif Cancer J Clin 1998:48:31-48.
3. Rimer BK, Herman D, Crawford J, Blackwell S. Lung cancer in North Carolina. NC Med J 1993;54:334-340.
4. Eddy DM. Screening for lung cancer. Ann Intern Med 1989; 111: 232-7.
5. Ihde DC. Chemotherapy of lung cancer. N Engl J Med 1992;327: 1434-41.
6. Devesa SS, Shaw GL, Blot WJ. Changing patterns of lung cancer incidence by histological type. Cancer Epidemiol Biomarker Prev 1991;1:29-34.
7. Matthews MJ, Mackay B, Lukeman J. The pathology of non-small cell carcinoma of the lung. Semin Oncol 1983;10:34-55.
8. Akiba S., Kato H, Blot W. Passive smoking and lung cancer among Japanese women. Cancer Res 1986;46:4804-7.
9. Woodward A. McMichael AJ. Passive smoking and cancer risk: the nature and uses of epidemiological evidence. Eur J Cancer 1991;27:1472-9.
10. Fontham ET., Correa P, Reynolds P. et al. Environmental tobacco smoke and lung cancer in nonsmoking women: a multicenter study. JAMA 1994;271:1752-9.
11. Harris RE, Zang EA, Anderson JI, Wynder EL. Race and sex differences in lung cancer risk associated with cigarette smoking. Int J Epidemiol 1993;22:592-9.
12. Garfinkel L., Silverberg E. Lung cancer and smoking trends in the United States over the past 25 years. CA Cancer J Clin 1991; 41: 137-45.
13. Le Marchand L, Hankin JH, Kolonel LN, Beecher GR, Wilkens LR, Zhao LP. Intake of specific carotenoids and lung cancer risk. Cancer Epidemiol Biomarkers Prev 1993;2:183-7.
14. Dorgan JF., Ziegler RG, Schoenberg JB, et al. Race and sex differences in associations of vegetables, fruits, and carotenoids with lung cancer risk in New Jersey. Cancer Causes Control 1993:4: 273-81.
15. van den Brandt PA, Goldbohm RA, van der Veer P, Bode P., Dorant E, Hermus RJ, Sturmans FA. Prospective cohort study on selenium status and the risk of lung cancer. Cancer Res 1993;53: 4860-5.
16. Burns PB, Swanson GM. The Occupational Cancer Incidence Surveillance Study (OCISS): risk of lung cancer by usual occupation and industry in the Detroit metropolitan area. Am J Indust Med 1991.19:655-71.
17. Tirmache M, Raphalen A, Chameaud J. Epidemiology study of French uranium miners. Cancer Detect Prev 1992;16:169-72.
18. Morabia A, Markowitz S, Garibaldi K, Wynder EL. Lung cancer and occupation: results of multicenter case-control study. Br J Indust Med 1992;49:721-7.
19. Brownson RC, Alavanja MC, Chang JC. Occupational risk factors for lung cancer among nonsmoking women: a case-control study in Missouri. Cancer Causes Control 1993;4:449-54.
20. Swanson GM, Lin CS, Bums PB. Diversity in the association between occupation and lung cancer among black and white men. Cancer Epidemiol Biomarkers Prev 1993;2:313-20.
21. Kaysouyanni K. Trichopoulos D. Kalandidi A, Tomos P, Riboli E. A case-control study of air pollution and tobacco smoking in lung cancer among women in Athens. Prev Med 1991;20:271-8.
22. Becher H, Jedrychowski W, Wahrendorf J, Basa-Cierpialek Z, Flak E, Gomola K. Effect of occupational air pollutants on various histological types of lung cancer: a population based case-control study. Br J Indust Med 1993;50:136-42.
23. Moolgavkar SH. Luebeck EG, Krewski D, Zielinski JM. Radon, cigarette smoke, and lung cancer: a re-analysis of the Colorado Plateau uranium miners’ data. Epidemiology 1993;4:204-17.
24. Samet JM, Nero AV. Indoor radon and lung cancer. N Engl J Med 1989;320:591-3.
25. Mossman BT, Gee JBL. Asbestos-related diseases. N Engl J Med 1989:320:1721-30.
26. Sellers TA, Bailey-Wilson JE, Elston RC, et al. Evidence for Mendel ian inheritance in the pathogenesis of lung cancer. J Natl Cancer Inst 1990;82:1272-9.
27. Ooi WL, Elston RC, Chen VW, Bailey-Wilson JE, Rothschild H. Increased familial risk for lung cancer. J Natl Cancer Inst 1986; 76:217-22.
28. Gauderman W. Morrison J, Carpenter C, Thomas D. Analysis of gene-smoking interaction in lung cancer. Genet Epidemiol 1997; 14:199-214.
29. Tokuhata GK, Lilienfeld AM. Familial aggregation of lung cancer in humans. J Natl Cancer Inst 1963;30:289-312.
30. Osann KE. Lung cancer in women: the importance of smoking, family history of cancer, and medical history of respiratory disease. Cancer Res 1991; 51:4893-7.
31. Spitz MR, Bondy ML. Genetic susceptibility to cancer. Cancer 1993;72(suppl 3):991-5.
32. Wu X, Hsu TC, Annegers JF. Amos Cl, Fueger JJ, Spitz MRA. Case-control study of nonrandom distribution of bleomycin-induced chromatid breaks in lymphocytes of lung cancer cases. Cancer Res 1995;55:557-61.
33. Spitz MR, Hsu TC, Wu X, Fueger JJ, Amos CI, Roth JA. Mutagen sensitivity as a biological marker of lung cancer risk in African Americans. Cancer Epidemiol Biomarkers Prev 1995;4:99-103.
34. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease: ten year follow-up from the nurses health study. N Engl J Med 1991;325:756-62.
35. Cauley JA, Gutai JP, Kuller LH, Dai WS. Usefulness of sex steroid hormone levels in predicting coronary artery disease in men. Am J Cardiol 1987;60:771-7.
36. Barrett-Connor E, Khaw K. Endogenous sex hormones and cardiovascular disease in men: a prospective population-based study. Circulation 1988;78:539-45.
37. Hamilton JB, Mestler GE. Mortality and survival: comparison of eunuchs with intact men and women in a mentally retarded population. J Gerontol 1969;24:395-411.
38. Group VAC-OUR. Treatment and survival of patients with cancer of the prostate. Surg Gynecol Obstet 1967; 124:1011-7.
39. McWilliams J. Sanderson B, Harris E, Richert-Boe K. Henner W. Glutathione S-transferase M1 (GSTMI) deficiency and lung cancer risk. Cancer Epidemiol Biomarker Prev 1995;4:589-94.
40. Rebbeck T. Molecular epidemiology of the human glutathione S-transferase genotypes GSTMI and GSTTJ in cancer susceptibility. Cancer Epidemiol Biomarker Prev 1997;6:733-43.
41. Ford J, Li Y, Brandt-Rauf P, O’Sullivan M, Garte S, Taioli E. Glutathione S-transferase Ml (GSTMI) polymorphism and lung cancer risk in African-Americans. Proc AACR 1998;39:365.
42. Hayashi S, Watanabe J, Nakachi K, Kawajiri K. Genetic linkage of lung cancer-associated Msp\ polymorphisms with amino acid replacement in the heme binding region of the human cytochroma F4501AI gene. J Biochem 1991; 110:407-2.
43. Nakachi K, Imai K, Hayashi S, Watanabe J, Kawajiri K. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res 1991;51:5177-80.
44. Hamada G, Sugimura H, Suzuki I. et al. The heme-binding region polymorphism of cytochrome P450IAI (CyplAl), rather than the Rsa1 polymorphism of IIEI (Cyp2EI). is associated with lung cancer in Rio de Janeiro. Cancer Epidemiol Biomarker Prev 1995;4: 63-7.
45. Nakachi K, Imai K, Hayashi S, Kawajiri K. Polymorphisms of the CYPIAl and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res 1993;53:2994-9.
46. Oyama T, Kawamoto T, Mizoue T, et al. Cytochrome P450 2E1 polymorphism as a risk factor for lung cancer: in relation to p53 gene mutation. Anticancer Res 1997;17:583-8.
47. Daly AK, Cholerton S, Gregory W, Idle JR. Metabolic polymorphisms. Pharmacol Ther 1993;57:129-60.
48. Daly AK, Brockmoeller J, Broly F. et al. Nomenclature for human CYP2D6 alleles. Pharmacogenetics 1996;6:193-201.
49. London S, Daly A, Leathart J, Navidi W, Carpenter C, Idle J. Genetic polymorphism of CYP2D6 and lung cancer risk in African-Americans and Caucasian-Americans in Los Angeles County. Carcinogenesis 1997; 18:1203-14.
50. Femandez-Salguero P. Hoffman S. Cholerton S. et al. A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles. Am J Hum Genet 1995:57:651-60.
51. London S., Lehman T, Taylor J. Myeloperoxidase genetic polymorphism and lung cancer risk. Cancer Res 1997:57:5001-3.
52. Ambrosone C, Freudenheim J, Graham S, et al. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA 1996;276:1494-501.
53. Rosvold E, McGlynn K, Lustbader E, Buetow K. Identification of an NAD(P)H: quinone oxidoreductase polymorphism and its association with lung cancer and smoking. Pharmacogenetics 1995; 5:199-206.
54. Wienke J, Spitz M, McMillan A, Kelsey K. Lung cancer in Mexi-can-Americans and African-Americans is associated with the wild-type genotype of the NAD(P)H: quinone oxidoreductase polymorphism. Cancer Epidemiol Biomarker Prev 1997;6:87-92.
55. Jeffreys AJ. Wilson V. Thein SL. Hypervanable “minisatellite” regions in human DNA. Nature 1985;314:67-73.
56. Krontiris TG., DiMartino NA, Colb M, Parkinson DR. Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumour DNAs of cancer patients. Nature 1985:313:369-74.
57. Krontiris TG, Devlin B, Karp DD. Robert NJ, Rise N. An association between the risk of cancer and mutations RASI minisatellite locus. N Engl J Med 1993;329:517-23
58. Phelan C, Rebbeck T, Weber B. et al. Ovarian in BRCA1 carriers is modified by the HRASI variable tandem repeat (VNTR) locus. Nature Genet 1996; 12 309